Journal of Neuro-Oncology

Article	Citations
Immune suppression in gliomas	158
A review of glioblastoma immunotherapy	149
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis	109
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature	65
Response to trametinib treatment in progressive pediatric low-grade glioma patients	64
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and	62
Awake glioma surgery: technical evolution and nuances	59
Convection-enhanced drug delivery for glioblastoma: a review	50
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer	48
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma	48
Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database	44
Boron neutron capture therapy for malignant brain tumors	44
Intraoperative MRI for Brain Tumors	43
Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery	42
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial	41
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma	41
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor	40
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review	37
Combination immunotherapy strategies for glioblastoma	37
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection	36
Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience	36
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice	35
Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review	35
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity	33
Neurotoxicities associated with immune checkpoint inhibitor therapy	32

T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment	31
Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases	30
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review	30
Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi-institutional series	29
Diffuse midline glioma: review of epigenetics	28
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics	28
Serum microRNA is a biomarker for post-operative monitoring in glioma	27
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid	27
Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes	27
Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma	26
Label-free brain tumor imaging using Raman-based methods	26
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)	26
Focused ultrasound for the treatment of glioblastoma	25
MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region	25
Surgical strategy for insular glioma	25
Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state	24
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma	24
Descriptive epidemiology of chordomas in the United States	24
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma	24
Sonodynamic therapy for gliomas	24
Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic	24
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study	23
Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference	23
Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma	23
The ability to return to work: a patient-centered outcome parameter following glioma surgery	22
Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice	22
Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic	22
Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature	22
Molecular characteristics and clinical features of multifocal glioblastoma	22
Reconstruction after endoscopic surgery for skull base malignancies	22
Cyproterone acetate and meningioma: a nationwide-wide population based study	21
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis	21
Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis	21
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study	21
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation	21
Molecular markers and targeted therapy in pediatric low-grade glioma	21
LAG-3 expression in the inflammatory microenvironment of glioma	21
Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma	21
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma	20
Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow	20
Radiomics for precision medicine in glioblastoma	20
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival	20
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience	20
Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase	20
May we deliver neuro-oncology in difficult times (e.g. COVID-19)?	19
H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients	19
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases	19
Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey	19
Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series	19
Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study	19

Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification	19
Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection	19
A novel online calculator predicting short-term postoperative outcomes in patients with metastatic brain tumors	19
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation	19
The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update	18
Modern endoscopic skull base neurosurgery	18
Update on management of craniopharyngiomas	18
Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis	18
Unexpected hubness: a proof-of-concept study of the human connectome using pagerank centrality and implications for intracerebral neurosurgery	18
The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes	18
Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma	18
Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors	17
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma	17
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update	17
Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas	17
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma	17
Clinical presentation of young people (10–24 years old) with brain tumors: results from the international MOBI-Kids study	17
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma	17
Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database	17
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates	16
Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema	16
Extent of resection and survival outcomes in World Health Organization grade II meningiomas	16
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients	16
Resected WHO grade I meningioma and predictors of local control	16
Immune checkpoint inhibitors in GBM	16
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	16
Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping	16
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma	16
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation	16
In silico analysis of the immunological landscape of pituitary adenomas	16
Fluorescein-mediated sonodynamic therapy in a rat glioma model	16
Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients	16
Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis	15
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases	15
Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound	15
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults	15
Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma	15
Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation	15
The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma	15
Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival	15
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases	15
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma	15
The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring	15
Predictors of postoperative biochemical remission in acromegaly	15
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment	15
Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma	15
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign	15
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival	15
Current state of therapeutic focused ultrasound applications in neuro-oncology	14
Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients	14
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma	14
Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study	14
Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms	14
RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping	14
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients	14
Determinants and predictors for the long-term disease burden of intracranial meningioma patients	14
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity	14
Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma	14
Predicting response to radiotherapy of intracranial metastases with hyperpolarized $$^{13}$$C MRI	14
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review	14
Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013	14
Osteoradionecrosis of the skull base	14
Magnetic resonance-guided laser interstitial thermal therapy for posterior fossa neoplasms	14
Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis	14
Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes	14
How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians	14
Impact of neurosurgical enhanced recovery after surgery (ERAS) program on health-related quality of life in glioma patients: a secondary analysis of a randomized controlled trial	14
Neuropsychological outcomes following supratotal resection for high‐grade glioma: a review	14
Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review	13
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?	13
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas	13
Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection?	13
Combined fluorescence-guided surgery and photodynamic therapy for glioblastoma multiforme using cyanine and chlorin nanocluster	13
Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory	13
Potential differences between monolingual and bilingual patients in approach and outcome after awake brain surgery	13
Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years	13
Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis	13
Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas	13
A systematic review of tumor treating fields therapy for high-grade gliomas	13
Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives	12

Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study	12
Predictors of long-term tumor control after stereotactic radiosurgery for Koos grade 4 vestibular schwannomas	12
Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide	12
Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma	12
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis	12
Stereotactic radiosurgery for acromegaly: an international systematic review and meta-analysis of clinical outcomes	12
Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection	12
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status	12
Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas	12
Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas	12
Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults	12
Emerging systemic treatment options in meningioma	12
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study	12
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression	12
Evolution of the neurosurgical management of progestin‐associated meningiomas: a 23-year single‐center experience	12
Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models	11
AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation	11
Diffusion tractography for awake craniotomy: accuracy and factors affecting specificity	11
Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients	11
Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas	11
Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases	11
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1	11
Radiotherapy alone for pediatric patients with craniopharyngioma	11
The Clinical Frailty Scale as useful tool in patients with brain metastases	11
Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma	11
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825	11
Long term outcomes following surgery for pineal region tumors	11
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography	11
Advances in the management of primary bone sarcomas of the skull base	11
Awake craniotomy for gliomas involving motor-related areas: classification and function recovery	11
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition	11
Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma	11
Leptomeningeal disease in glioblastoma: endgame or opportunity?	11
Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review	11
Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update	11
Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan	11
Symptomatic peritumoral edema is associated with surgical outcome: a consecutive series of 72 supratentorial meningioma patients ≥ 80 years of age	11
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression	11
Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma	11
Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas	11
End-of-life care for glioma patients; the caregivers’ perspective	11
Leptomeningeal metastases: the future is now	11
Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma	11
The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma	10
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints	10
Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome	10
Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice	10
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes	10
Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma	10
Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant	10
Management of incidental anterior skull base large and giant meningiomas in elderly patients	10
Impact of the COVID-19 pandemic on neuro-oncology outcomes	10
Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy	10
Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade	10
Pattern of technology diffusion in the adoption of stereotactic laser interstitial thermal therapy (LITT) in neuro-oncology	10
Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas	10
The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications	10
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine	10
Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR	10
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis	10
Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases	10
Tumor location-based classification of surgery-related language impairments in patients with glioma	10
Fluorescence guided surgery for pituitary adenomas	10
Distinct topographic-anatomical patterns in primary and secondary brain tumors and their therapeutic potential	10
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis	10
What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?	10
Final results of the Choroid Plexus Tumor study CPT-SIOP-2000	10
Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy	10
eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial	10
Radiotherapy for meningiomas	9
Updates on the WHO diagnosis of IDH-mutant glioma	9
Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition	9
Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours	9
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide	9
Cervical chordomas: multicenter case series and meta-analysis	9
18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection	9
Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients	9
The application of fluorescein sodium for the resection of medulloblastoma	9
Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses	9
Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study	9
A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care	9
Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis	9
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology	9
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification	9
Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs	9
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients	9
Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer	9
Endoscopic-assisted surgical approach for butterfly glioma surgery	9
Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US	9
Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery	9
Utility of hospital frailty risk score for predicting postoperative outcomes in craniopharyngioma	9
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age	9
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness	9
Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors	9
Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas	9